Thomas James D 4

What Happened

• Thomas James (Chief Financial Officer of Nu Skin Enterprises, Inc.) was granted 114,706 shares on March 6, 2026. The Form 4 reports the transaction as an award/grant (transaction code A) with an acquisition price of $0 — i.e., awarded shares rather than an open-market purchase or sale. This is a compensation-related equity grant, not a sale.

Key Details

• Transaction date: 2026-03-06; Form 4 filed: 2026-03-09 (Accession No. 0001021561-26-000034).
• Shares granted: 114,706; reported acquisition price: $0.00.
• Shares owned after transaction: not specified in the provided filing details.
• Transaction type/code: A (award/grant/other acquisition). No footnotes or 10b5-1 / tax-withholding details were provided in the supplied data.
• Timeliness: Filing date (3/9/2026) is within the Form 4 reporting window for the 3/6/2026 transaction (not marked late).

Context

• Awards like this are typically part of executive compensation (e.g., restricted stock or performance shares) and often vest over time; they are not the same as an insider buying stock on the open market, so they don't directly signal personal cash investment.
• Because the filing does not disclose vesting terms or post-transaction holdings here, investors should consult the full Form 4 or company proxy/compensation disclosures for details on vesting, restrictions, and the grant’s economic value.